BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23782518)

  • 1. Normal and cancer stem cells of the human female reproductive system.
    López J; Valdez-Morales FJ; Benítez-Bribiesca L; Cerbón M; Carrancá AG
    Reprod Biol Endocrinol; 2013 Jun; 11():53. PubMed ID: 23782518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell properties and epithelial malignancies.
    Mackenzie IC
    Eur J Cancer; 2006 Jun; 42(9):1204-12. PubMed ID: 16644206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System.
    Knapp P; Chomicz K; Świderska M; Chabowski A; Jach R
    Biomed Res Int; 2019; 2019():4376583. PubMed ID: 31187044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal stem cells in cancer prone epithelial tissues.
    Phesse TJ; Clarke AR
    Br J Cancer; 2009 Jan; 100(2):221-7. PubMed ID: 19127254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
    Nakamura M; Zhang X; Mizumoto Y; Maida Y; Bono Y; Takakura M; Kyo S
    Int J Oncol; 2014 Mar; 44(3):669-77. PubMed ID: 24366104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise.
    Abd GM; Laird MC; Ku JC; Li Y
    Front Oncol; 2023; 13():1227884. PubMed ID: 37614497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Carcinoma: Oncobiology and Biomarkers.
    Volkova LV; Pashov AI; Omelchuk NN
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
    Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type.
    Sims LB; Curry KC; Parupalli S; Horner G; Frieboes HB; Steinbach-Rankins JM
    Pharm Res; 2019 Mar; 36(5):66. PubMed ID: 30868271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma.
    Tulake W; Yuemaier R; Sheng L; Ru M; Lidifu D; Abudula A
    Oncol Lett; 2018 Nov; 16(5):5525-5534. PubMed ID: 30344706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue.
    Sims LB; Huss MK; Frieboes HB; Steinbach-Rankins JM
    J Nanobiotechnology; 2017 Oct; 15(1):67. PubMed ID: 28982361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of CD133 expression in Endometrial Cancer Patients.
    Mancebo G; Sole-Sedeno JM; Pino O; Miralpeix E; Mojal S; Garrigos L; Lloveras B; Navarro P; Gibert J; Lorenzo M; Aran I; Carreras R; Alameda F
    Sci Rep; 2017 Aug; 7(1):7687. PubMed ID: 28794448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular signaling entropy can be a biomarker for predicting the development of cervical intraepithelial neoplasia.
    Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Ogishima J; Eguchi S; Yamashita A; Tomio K; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
    PLoS One; 2017; 12(4):e0176353. PubMed ID: 28453530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.
    Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Ogishima J; Eguchi S; Yamashita A; Tomio K; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
    Oncotarget; 2017 Jun; 8(25):40935-40945. PubMed ID: 28402962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets.
    Naik RR; Gardi NL; Bapat SA
    Sci Rep; 2016 May; 6():25261. PubMed ID: 27140846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer transformation from adenocarcinoma to undifferentiated small cell carcinoma: A case report.
    Huang ZP; Liu XJ; Zou BX; Shen Q; Liu Y; Zhou T
    Oncol Lett; 2015 May; 9(5):2230-2232. PubMed ID: 26137046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.
    Lv Y; Yang L; Wang F
    Med Oncol; 2015 May; 32(5):155. PubMed ID: 25837433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cues on obesity signals, tumor markers and endometrial cancer.
    Daley-Brown D; Oprea-Ilies GM; Lee R; Pattillo R; Gonzalez-Perez RR
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):89-106. PubMed ID: 25781554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting TBP-Associated Factors in Ovarian Cancer.
    Ribeiro JR; Lovasco LA; Vanderhyden BC; Freiman RN
    Front Oncol; 2014; 4():45. PubMed ID: 24653979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.